Retail chatter surged for Abbott and Dexcom on Tuesday after U.S. Health Secretary Robert F. Kennedy Jr. announced a sweeping ...

Pre-earnings options volume in DexCom (DXCM) is 2.4x normal with puts leading calls 7:5. Implied volatility suggests the market is anticipating a move near 6.7%, or $5.59, after results are ...

DexCom's (DXCM) shares have rallied nearly 7% over the past week, presumably on positive outlook for its CGM devices amid rising competition.

If you're using a Dexcom G7 to monitor your blood sugar in real-time, you can now sync it to your Apple Watch for real-time monitoring. Here's how.

Right now, DexCom's stock is valued at a price-to-earnings (P/E) multiple of 42. Assuming that valuation holds up over time, it'd have a market cap of roughly $469 billion in 2034, or 1,605% ...

DexCom DXCM shares soared 7.3% in the last trading session to close at $102.14.The move was backed by solid volume with far more shares changing hands than in a normal session. This compares to ...

Dexcom's shares fell nearly 37% last year, largely due to a slump in July after the company slashed its annual revenue forecast, blaming a restructuring of its sales team, fewer customers and ...

Outlook: DexCom affirmed its fiscal 2024 sales outlook of between $4 billion and $4.05 billion. DXCM Price Action: According to Benzinga Pro , DexCom shares are down 7.94% after-hours at $68.91 at ...

Medical device maker Dexcom cut its annual revenue forecast on Thursday, blaming a restructuring of its sales team, fewer customers, and lower revenue from each customer, sending its shares ...

DexCom (DXCM -42%), which is a major supplier of continuous glucose monitoring (CGM) systems for diabetes, is trading sharply lower today following earnings last night.The company beat on Q2 EPS but ...

DexCom's DXCM shares have risen 6.9% since Tuesday last week, while yesterday’s after-market movement took the rally to nearly 8%. Last week, the company presented a positive picture for its ...